• LAST PRICE
    2.7200
  • TODAY'S CHANGE (%)
    Trending Up0.0800 (3.0303%)
  • Bid / Lots
    2.5000/ 2
  • Ask / Lots
    2.9600/ 1
  • Open / Previous Close
    2.6800 / 2.6400
  • Day Range
    Low 2.5560
    High 2.8300
  • 52 Week Range
    Low 1.2350
    High 10.2000
  • Volume
    188,154
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 2.64
TimeVolumeLPTX
09:32 ET27892.69
09:33 ET7122.5655
09:35 ET1002.6181
09:37 ET7012.5623
09:42 ET11002.616
09:44 ET50002.556
09:46 ET143932.7
09:48 ET3002.6
09:50 ET3692.6
09:53 ET2502.5613
09:55 ET6482.625
10:06 ET2002.61
10:13 ET1002.64
10:15 ET1002.64
10:22 ET6242.635
10:26 ET1002.6343
10:36 ET2002.65
10:40 ET10002.635
10:47 ET12002.64
10:49 ET1002.64
11:03 ET2002.63
11:05 ET2002.63
11:07 ET1002.62
11:09 ET1002.62
11:16 ET1002.64
11:18 ET27002.64
11:20 ET6002.62
11:25 ET1002.6385
11:27 ET9172.62
11:30 ET117102.61
11:32 ET5002.6
11:34 ET5002.5801
11:39 ET6502.62
11:43 ET1002.62
11:48 ET70062.66
11:50 ET7002.7
11:54 ET98682.69
11:57 ET12102.67
11:59 ET21002.685
12:01 ET1502.6969
12:03 ET1002.69
12:10 ET64002.72
12:12 ET39852.73
12:14 ET14002.7199
12:21 ET19972.71
12:26 ET2002.725
12:30 ET1002.725
12:32 ET19602.755
12:33 ET9792.755
12:35 ET3002.7201
12:39 ET23002.755
12:42 ET34002.755
12:46 ET2202.775
12:48 ET5002.78
12:50 ET4322.7949
12:53 ET22602.79
01:02 ET11002.79
01:04 ET63692.82
01:08 ET18002.82
01:22 ET16232.83
01:26 ET51992.815
01:27 ET31202.81
01:31 ET2502.8001
01:33 ET26092.805
01:38 ET51952.77
01:40 ET1002.775
02:00 ET23992.7899
02:02 ET3002.78
02:03 ET2002.78
02:05 ET8342.78
02:09 ET16002.76
02:12 ET2002.76
02:14 ET1002.76
02:20 ET26502.765
02:21 ET1852.7532
02:23 ET3802.755
02:25 ET2102.74
02:32 ET26202.7101
02:45 ET15502.695
02:48 ET9002.695
02:50 ET8002.69
02:52 ET2002.7
02:54 ET4002.74
02:56 ET1002.715
02:57 ET58092.7
02:59 ET5002.69
03:01 ET5542.69
03:03 ET10002.69
03:06 ET82002.72
03:10 ET1002.7426
03:14 ET58902.7
03:17 ET2002.6994
03:24 ET1002.69
03:26 ET2002.695
03:28 ET2452.68
03:30 ET10002.6874
03:35 ET1002.69
03:44 ET1002.695
03:46 ET1002.71
03:48 ET17392.71
03:50 ET2202.71
03:51 ET7312.71
03:53 ET24762.7
03:55 ET2002.6823
03:57 ET3012.7
04:00 ET33622.72
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLPTX
Leap Therapeutics Inc
67.5M
-0.5x
---
United StatesNKGN
NKGen Biotech Inc
66.5M
-0.9x
---
United StatesCKPT
Checkpoint Therapeutics Inc
68.0M
-0.6x
---
United StatesKRON
Kronos Bio Inc
68.8M
-0.6x
---
United StatesBIVI
BioVie Inc
65.7M
-1.2x
---
United StatesBCAB
Bioatla Inc
65.7M
-0.5x
---
As of 2023-12-05

Company Information

Leap Therapeutics, Inc. is a biotechnology company. The Company is focused on developing targeted and immuno-oncology therapeutics. Its advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. DKK1 modulates the Wnt/Beta-catenin and PI3kinase/AKT signaling pathways and promotes tumor proliferation, metastasis, angiogenesis, and in mediating an immune suppressive tumor microenvironment through enhancing the activity of myeloid-derived suppressor cells and downregulating NK cell ligands on tumor cells. The Company’s pipeline includes FL-301, a humanized monoclonal antibody targeting Claudin18.2, being developed in patients with gastric and pancreatic cancer. Claudin18.2 regulates barrier properties and contributes to cell-to-cell adhesion. It also has preclinical antibody programs targeting Claudin18.2/CD137 and GDF15.

Contact Information

Headquarters
47 Thorndike St Ste B1-1CAMBRIDGE, MA, United States 02141-1799
Phone
617-252-4343
Fax
302-636-5454

Executives

Chairman of the Board
Christopher Mirabelli
President, Chief Executive Officer, Director
Douglas Onsi
Chief Operating Officer
Augustine Lawlor
Chief Scientific Officer
Jason Baum
Vice President, Head - Regulatory Affairs and Quality
Christine Granfield

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$67.5M
Revenue (TTM)
$0.00
Shares Outstanding
25.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.40
EPS
$-5.72
Book Value
$5.94
P/E Ratio
-0.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.